Threat of Drug-Resistant Bacteria Will Grow Unless Congress Steps In, Experts Say

A pharmacy technician counts out a prescription of antibiotic pills in Miami, Fla., on Aug. 7, 2007. Joe Raedle/Getty Images

The increasing public health threat of antimicrobial resistance (AMR) is already putting vulnerable patients at risk, but Congress could step in to help, experts say.

Testifying on July 11 before the Senate Health, Education, Labor, and Pensions Committee, Christine Ann Miller, the president and CEO of Melinta Therapeutics, noted that AMR is a very current concern.